Document:

QuickLinks
 -- Click here to rapidly navigate through this document
  

Exhibit 10.24  

 
 

COMMISSION AGREEMENT    
    

        This
Commission Agreement ("Agreement") is made as of August 10, 2006 ("Effective Date"), by and between ACCURAY INCORPORATED, a
California Corporation with offices located at 1310 Chesapeake Terrace, Sunnyvale, California 94089, ("Accuray"), and PRESIDENT MEDICAL
TECHNOLOGIES CO., LTD. INC., a Taiwanese corporation, located at 8F., No. 1, Guangfu S. Rd., Taipei 105, Taiwan, Republic of China ("PMTC"), each
separately being a "Party" and collectively the "Parties". 

        WHEREAS,
the Parties entered into an Amended and Restated International Distributor Agreement ("Distributor Agreement") on April 1, 2004, naming PMTC as Accuray's exclusive
distributor in certain specified territories, and pursuant to which PMTC is to receive a commission on the sale of CyberKnife Stereotactic Radiosurgery Systems within those territories; 

        WHEREAS,
PMTC consented by way of a letter dated December 28, 2005 to allow Accuray to sell a CyberKnife System to Hong Kong Adventist Hospital ("HKAH"), which is located within
PMTC's exclusive territory; and 

        WHEREAS,
Accuray desires to pay PMTC an appropriate commission for the sale of the CyberKnife System to HKAH as specified herein. 

        THEREFORE,
the Parties hereby agree as follows: 

        1.    HKAH Agreement.    On December 30, 2005 Accuray entered into a CyberKnife Quotation and Purchase
Agreement with HKAH for the sale of a CyberKnife System at a total price of U.S. $[*], which contained the following payment terms: 

	•
	$50,000
with Signed Letter of Intent (received by PMTC)

	•
	$[*]
due with Signed Agreement (to be signed by December 30, 2005.) Payment by Letter of Credit or T/T to Accuray Incorporated's bank
account, upon Customer receiving Hong Kong Government Approval to proceed with project, by no later than January 31, 2006.

	•
	$[*]
due upon shipment of the CyberKnife G4 System (estimated shipment date is July 31, 2006. Payment by Letter of Credit or T/T to
Accuray Incorporated's bank account within five (5) business days after shipment. Accuray will provide a Bill of Lading to Hong Kong Adventist Hospital for payment purposes).

	•
	$[*]
due within 30 days of first patient treatment, or November 30, 2006, whichever occurs first, by Letter of Credit or T/T to Accuray
Incorporated's bank account 

        2.    PMTC Commission.    Accuray and PMTC have agreed that PMTC will receive a commission on the HKAH sale in the
amount of U.S. $[*], as set forth in the Commission Analysis attached hereto as Exhibit A ("Commission"). The Commission was determined by taking into account
PMTC's anticipated margin on an equivalent sale, and the additional costs incurred by Accuray as a result of promises made by PMTC to HKAH in the Letter of Intent signed by PMTC and HKAH. PMTC's
Commission will be paid according to the following schedule, which approximates the payment schedule in the HKAH Purchase Agreement: 

Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request.
Omissions are designated as
[*]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

1

 

	2.1.
	Thirteen
percent (13%) of the Commission, U.S. $[*], less the U.S. $50,000 already received by PMTC from HKAH upon signing the Letter of Intent,
for a net payment of U.S. $[*], will be paid within thirty (30) days of signing this Agreement;

	2.2.
	Eighty
one percent (81%) of the Commission, or U.S. $[*], will be paid within thirty (30) days of receipt by Accuray of the full payment due
upon shipment of the CyberKnife System to HKAH; and

	2.3.
	Six
percent (6%) of the Commission, or U.S. $[*], will be paid within thirty (30) days of receipt by Accuray of the full payment due following
first patient treatment by HKAH. 

        3.    Marketing Assistance.    One of the additional items promised by PMTC to HKAH was
U.S. $[*] in marketing assistance, particularly in support of the grand opening of the CyberKnife Center at HKAH. Accuray will provide marketing assistance to HKAH up to
U.S. $[*], which amount has been deducted from PMTC's Commission. 

        4.    Assignment.    Neither party may assign this Agreement without the other party's prior written consent, except
that Accuray may assign this Agreement, without PMTC's consent, to an affiliate or to a successor or acquirer, as the case may be, in connection with a merger or acquisition, or the sale of all or
substantially all of Accuray's assets or the sale of that portion of Accuray's business to which this Agreement relates. Subject to the foregoing, this Agreement will bind and inure to the benefit of
the parties' permitted successors and assigns. 

        5.    Notices.    All notices required or permitted under this Agreement will be in writing and delivered in person,
by overnight delivery service, or by registered or certified mail, postage prepaid with return receipt requested, and in each instance will be deemed given upon receipt. All communications will be
sent to the addresses set forth below or to such other address as may be specified by either party in writing to the other party in accordance with this Section. 

	To Accuray:	 	To PMTC:
	
 Accuray Incorporated

Attention: CFO

1310 Chesapeake Terrace

Sunnyvale, CA 94089

U.S.A.	
 	

President Medical Technologies Co., Ltd. Inc.

Attention: General Manager

8F., No. 1, Guangfu S. Rd.

Taipei 105, Taiwan

Republic of China
	
 with cc to: General Counsel	
 	

 

        6.    Disputes and Governing Laws    

	6.1.
	In
the event that a dispute arises between Accuray and PMTC with respect to the subject matter governed by this Agreement, such dispute shall be settled as follows. If either party
shall have any dispute with respect to this Agreement, that party shall provide written notification to the other party in the form of a claim identifying the issue or amount disputed including a
detailed reason for the claim. The party against whom the claim is made shall respond in writing to the claim within thirty (30) days from the date of receipt of the claim document. The party
filing the claim shall have an additional thirty (30) days after the receipt of the response to either accept the resolution offered by the other party or escalate the matter. If the dispute is
not resolved, either party may notify the other in writing of their desire to elevate the claim to the President of Accuray and the Chief Executive Officer of PMTC. Each shall negotiate in good faith
and use his or her best efforts to resolve such dispute or claim. The location, format, frequency, duration and conclusion of these elevated discussions shall be left to the discretion of the
representatives involved. If the negotiations do not lead to resolution of the underlying dispute or claim to the satisfaction of either party involved, then either party may pursue resolution by the
courts as follows. 

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

2

 

	6.2.
	All
disputes under any contract concerning the subject matter governed by this Agreement, not otherwise resolved between Accuray and PMTC shall be resolved in a court of competent
jurisdiction, in Santa Clara County, State of California, and in no other place. PMTC hereby consents to the jurisdiction of such court or courts and agrees to appear in any such action upon written
notice thereof. No action, regardless of form, arising out of, or in any way connected with, this Agreement or the Inventories, may be brought by PMTC more than one (1) year after the cause of
action has occurred. 

        7.    Waiver.    The waiver of any breach or default of any provision of this Agreement will not constitute a waiver
of any other right hereunder or of any subsequent breach or default. 

        8.    Severability.    If any provision of this Agreement is held invalid or unenforceable by a court of competent
jurisdiction, the remaining provisions of the Agreement will remain in full force and effect, and the provision affected will be construed so as to be enforceable to the maximum extent permissible
by law. 

        9.    Amendments.    Any amendment or modification of this Agreement must be made in writing and signed by duly
authorized representatives of each party. For Accuray, a duly authorized representative must be any of the following: CEO, CFO or General Counsel. 

        10.    Entire Agreement.    This Agreement, in combination with the Distributor Agreement, contains the entire
agreement between the parties hereto with respect to the subject matter herein, and supersedes all previous understandings, representations and warranties, agreements, written and oral, made and
entered into by and among Accuray and PMTC in relation to the HKAH CyberKnife System. 

        11.    Counterparts.    This Agreement may be executed in counterparts, each of which will be deemed an original, but
all of which together will constitute one and the same instrument. 

        IN
WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the date set forth below by their duly authorized representatives. The parties acknowledge and agree that
this Agreement does not become effective until it has been signed by all parties indicated below. 

	Accuray Incorporated	President Medical Technologies Co., Ltd. Inc.
	
 By: /s/ Robert E. McNamara                	

By: /s/ Huan Chiu Kuo                
	
 Print Name: Robert E. McNamara                	

Print Name: Huan Chiu Kuo                
	
 Title: SVP & CFO                	

Title: General Manager                
	
 Date: August 24, 2006                	

Date: August 10, 2006                
	
 /s/ Darren Milliken                        August 23, 2006

Darren J. Milliken

General Counsel

3

 

EXHIBIT A

 
 

PMTC's Commission Analysis    
    

	CYBERKNIFE SYSTEM PRICE
	 	Part #
	 	USD

	 	CyberKnife G4	 	022986	 	$[*]
	 	Xsight	 	22078	 	[*]
	 	CyRIS InView	 	22086	 	$[*]
	 	Additional CyRIS Multiplan	 	21695	 	$[*]
	 	Installation	 	 	 	[*]
	 	 	 	 	

	Sub-Total for System Price:	 	 	 	$[*]
	 	 	 	 	

	
ADDITIONAL ITEMS PROMISED IN LETTER OF INTENT	
 	

 	
 	

 
	 	A: Extended Warranty Cost:	 	 	 	$[*]
	 	 	 	 	

	 	 	2nd year Emerald	 	 	 	 
	 	B: Downtime compensation:	 	 	 	$[*]
	 	 	 	 	

	 	 	Six Calendar Months (in Emerald basis):	 	 	 	 
	 	C: Training Tuition and T&E Cost:	 	 	 	 
	 	 	Tuition for extra six (6) personnel:	 	 	 	$[*]
	 	 	Air ticket (economic class) for eleven (11):	 	 	 	$[*]
	 	 	Hotel Accommodation for eleven (11) each seven nights:	 	 	 	$[*]
	 	 	 	 	

	 	Sub-Total for C:	 	 	 	$[*]
	 	 	 	 	

	 	D: Shipment and Insurance	 	 	 	$[*]
	 	 	 	 	

	 	 	Air-flight with insurance:	 	 	 	 
	 	E: Other Marketing Expenses	 	 	 	$[*]
	 	 	 	 	

	 	 	Grand opening ceremony & MISC	 	 	 	 
	Sub-Total for Additional Items:	 	 	 	$[*]
	 	 	 	 	

	Total Cost Incurred:	 	 	 	$[*]
	 	 	 	 	

	System Price to HKAH:	 	 	 	$[*]
	 	 	 	 	

	Commission to PMTC: System Price — Total Cost Incurred	 	 	 	$[*]
	 	 	 	 	

	Less: Down payment on LOI received from HKAH	 	 	 	$[*]
	 	 	 	 	

	Commission Still Owed to PMTC: Commission Less $50,000 LOI payment	 	 	 	$[*]
	 	 	 	 	

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

4

QuickLinks

COMMISSION AGREEMENT

PMTC's Commission AnalysisQuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.26  

 
 

ACCURAY INCORPORATED
  INTERNATIONAL DISTRIBUTOR AGREEMENT    
    

        This
International Distributor Agreement ("the Agreement") is entered into by and between Accuray Incorporated, a Delaware corporation with its executive offices located at
1310 Chesapeake Terrace, Sunnyvale, California 94089, USA, and Chiyoda Technol Corporation, a corporation organized under the laws of Japan, with its executive offices located at
1-7-12, Yushima, Bunkyo-ku, Tokyo 113-8681, Japan, as of                        , 2004
(the "Effective Date"). 

        Accuray
manufactures and sells full-body radiosurgery using image-guided robotics, including the CyberKnife, which is FDA approved to provide treatment planning and
image-guided stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body where radiation treatment is indicated. 

        In
order to achieve its business objectives, Accuray relies on qualified distributors to market and distribute its products and services in different territories. 

        Accuray
wishes to appoint Distributor as its exclusive distributor in Japan, subject to the terms and conditions of this Agreement and Distributor wishes to accept such appointment. 

1.     Definitions  

	1.1
	Accuray's Terms of Sale means the current standard international transaction terms and conditions of sale prepared by Accuray from time
to time and provided to Distributor.

	1.2
	Customer means any person or business entity lawfully doing business in the Territory with whom Distributor enters into an agreement
for Products or Services. Customer does not include hospitals located on United States armed forces bases in the Territory.

	1.3
	Products means the CyberKnife System and related products manufactured by or for Accuray for use in the radiosurgery market and listed
in Exhibit A attached to this Agreement, which have been approved for sale in the Territory.

	1.4
	Project means any activity or situation that includes a potential Customer or prospect that might be interested in acquiring Accuray's
Products or Services.

	1.5
	Proposal means a document that offers to provide Products or Services to a prospective Customer.

	1.6
	Purchase Order means a document provided by Distributor to Accuray that sets forth in adequate detail, including specifications and
delivery schedule, the Products or Services ordered.

	1.7
	Services means the performance of radiosurgery-related services by either Accuray or Distributor, which may include technical support,
training or installation of Products, as listed in Exhibit A.

	1.8
	Specification means the current written description of a Product or Service prepared by Accuray and provided to Distributor. 

Confidential
treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as
[*]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

	1.9
	Territory means Japan.

	1.10
	Transitional Customers means those Customers listed in Exhibit E who currently
have agreements with Meditec Corporation either (i) who have entered into a new agreement with Distributor or (ii) whose existing contracts with Meditec Corporation have been assigned to
Distributor pursuant to a separate agreement between Meditec Corporation and Distributor as contemplated by Section 3.8, below. 

2.     Duties of Accuray  

	2.1
	Status.    Accuray is responsible for ensuring that the Products supplied are of good quality as further described below.

	2.2
	Exclusive Distributor.    Accuray hereby appoints Distributor as the exclusive distributor of Products and Services to
Customer in the Territory, subject to the terms and conditions of this Agreement. So long as Distributor achieves the volume of business set forth below and otherwise meets its obligations under this
Agreement, Distributor shall be the exclusive distributor of Products and Services to Customer in the Territory.

	2.3
	Products and Services.    Accuray will use commercially reasonable efforts to provide timely to Distributor those Products
and Services required to fill orders received from Distributor in accordance with the terms of this Agreement.

	2.4
	Product and Service Pricing.    Accuray will provide Product and Service pricing to Distributor from time to time during the
Term of this Agreement. Products and Services shall be priced by Accuray to Distributor in accordance with Accuray's price list in effect from time to time, provided that Accuray will not increase the
pricing of any Product or Service before December 31, 2005 (approximately two years) unless there has been a configuration change or an expansion of the, approved clinical indications, but, in
any case, no change can be made without six months' prior written notice to Distributor. The current prices, as of the Effective Date, of Accuray's Products and Services are listed on  Exhibit A.
All prices will be stated in US Dollars.

	2.5
	Product Specifications and Promotional Literature.    Accuray will provide product specifications and promotional literature
to Distributor from time to time during the Term of this Agreement. Distributor may use product specifications and promotional literature in Distributor's dealings with Customers. Accuray may
introduce changes and upgrades to the Products. Accuray will be responsible for ensuring that any changes or upgrades to the Products comply with the latest regulatory approvals, and will use
commercially reasonable efforts to give Distributor as much advance notice of upgrades as is feasible.

	2.6
	Shonin.    Accuray will be responsible for obtaining the Shonin from the Japanese MHLW for the CyberKnife II system
(as specified in the Shonin application, which may be updated as necessary) for head and neck applications, and for any changes or upgrades to the Products. Accuray will be responsible for
(i) managing and paying for any paperwork associated with obtaining the Shonin; (ii) the costs of seeking approval for expanded usage of the CyberKnife II system and other Products;
(iii) timely application for all upgrades that Accuray determines are commercially appropriate; and (iv) maintaining the Shonin, all with the reasonable assistance of Distributor. At
Distributor's request, Accuray will provide Distributor an update of all Shonin-related activities at any time the Shonin is changed and up to two (2) additional times a year. Accuray shall
reimburse Distributor only for those Shonin-related expense incurred in connection with such assistance that have been pre-approved in writing by Accuray. 

2

 

	2.7
	Warranty.    Accuray will provide a warranty that the Products will be free from defects and perform substantially in
accordance with the Specifications as reflected in the Shonin at the time of sale for a period of one year following installation of the Product at Customer's facility, but not to exceed eighteen
(18) months following shipment of such Product to Distributor. Accuray makes no warranty that the operation of any software will be uninterrupted or error-free. Except as set forth
in the preceding sentences, Accuray makes no warranties or representations to Distributor or to any other party regarding any Products or Services provided by Accuray. To the fullest extent permitted
by applicable law, Accuray disclaims all other warranties and representations, whether express or implied, including, but not limited to, any implied warranties of merchantability, fitness for a
particular purpose or non-infringement, and any warranties arising out of course of dealing or usage of trade.

	2.8
	Support.    Accuray will provide Distributor the following types of support:

	2.8.1
	Hardware.    During the warranty period, Accuray will provide replacement of defective parts. This will be Accuray's sole
and exclusive obligation. Accuray shall not be responsible for the installation and labor costs for such replacement parts.

	2.8.2
	Hardware Parts Inventory.    Accuray will maintain an inventory of spare parts for the Products in the Territory.

	2.8.3
	Software.    During the warranty period, Accuray will provide error corrections or "bug fixes." This will be Accuray's sole
and exclusive obligation. Additionally, Accuray shall provide Distributor with any and all applicable error corrections and bug fixes generally provided by Accuray to Accuray customers with similar
Product installations.

	2.8.4
	Warranty Exclusions.    All warranty replacement of parts shall be limited to malfunctions which are due and traceable to
defects in original material or workmanship of Products. The warranties set forth in this Section 2 shall be void and of no further effect in the
event of abuse, accident, alteration, misuse or neglect of Products, including but not limited to user modification of the operating environment specified by Accuray and user modification of
any software.

	2.8.5
	Software Service Upgrades.    After the warranty period and subject to Distributor's mandatory purchase, pursuant to  Section 3.15, below, of an annual software service upgrade package as more fully described in
Exhibit A. Depending on the annual service upgrade package purchased by Distributor, such software service upgrades may include
new features.

	2.9
	Training.    Accuray will provide training to Distributor and, as applicable, to certain Transitional Customers, in
accordance with Exhibit C.

	2.10
	Clinical Trials.    Accuray and Distributor will work together to determine if clinical trials are necessary for the
regulatory approval of further CyberKnife applications or Products. If they determine that clinical trials are necessary, Accuray and Distributor will work together to design and conduct those trials.
Accuray will bear the incremental cost of the clinical trials, as well as the cost of submitting for regulatory approval. Notwithstanding the foregoing, Accuray shall not reimburse Distributor for any
expense incurred in connection with clinical trials or regulatory approval not pre-approved in writing by Accuray. At Accuray's request, Distributor will provide Accuray with receipts and
other documentation for all such expenses. Accuray shall not be responsible for Distributor's internal and existing resources for such activities.

	2.11
	Public Relations.    Accuray and Distributor will work together to design a public relations program. 

3

 

	2.12
	Compliance with Laws.    Accuray will be responsible for complying with U.S. laws and with Japanese laws as they
pertain to the Product and the Shonin. Upon notification by Distributor of any impending changes to Japanese laws or regulatory requirements that may necessitate modifications in the Products or
Services, Accuray shall respond to such notifications in a timely manner and make necessary efforts to ensure continued compliance. 

3.     Duties of Distributor  

	3.1
	Status.    Distributor shall be and must at all times make it clear that it is an independent entity contracting with
Accuray, and is not the employee, representative or agent of Accuray. Distributor does not have the ability or authority to enter into any legal agreements or obligations that would bind Accuray in
any manner. Distributor represents that it is involved in other businesses, not competitive with its activities under this Agreement but of sufficient volume and profitability that Distributor is in
no way dependent upon this Agreement or its relationship with Accuray for its continuing viability or success.

	3.2
	Training.    Distributor will provide training to Customer in accordance with Exhibit C.

	3.3
	Market Knowledge, Promotion and Sales.    Distributor represents that it has a thorough knowledge of the Territory, the
market for radiosurgery products and of all current and proposed Projects. Distributor will develop a thorough and complete understanding of the Products and Services. Distributor will use its
knowledge and understanding to develop potential Projects.

	3.3.1
	Distributor
will use best efforts to promote the sale of and to sell Products and Services to Customers in accordance with Accuray's marketing guidance and policies in effect from
time to time and will make best efforts to learn of any potential Project. Distributor will make itself familiar with each such Project so as to learn all conditions of the Project which may impact
the Products or Services to be offered. In addition, as Accuray releases new features and Products, Distributor will use best efforts to promote the sale of and to sell those features and Products to
the installed base of Products and to new Customers in the Territory.

	3.3.2
	Distributor
sales and marketing staff will actively participate in the following activities: American Society of Therapeutic Radiology & Oncology (ASTRO); American
Association of Neurological Surgeons (AANS); Accuray worldwide users' meeting; and Accuray worldwide
sales meetings. Active participation includes attendance at and participation in such meetings.

	3.3.3
	Distributor
will report to Accuray any proposed or pending Projects outside the Territory about which Distributor learns during the Term of this Agreement.

	3.4
	Shonin Assistance.    Distributor will give assistance where reasonable or requested by Accuray in connection with Accuray's
activities related to obtaining and maintaining the Shonin. Notwithstanding the foregoing, Accuray shall not reimburse Distributor for any Shonin-related expense incurred in connection with such
assistance not pre-approved in writing by Accuray. At Accuray's request, Distributor will provide Accuray with receipts and other documentation for all such expenses. Accuray shall not be
responsible for Distributor's internal administrative personnel or resources for such activities.

	3.5
	Import License.    Distributor will obtain and maintain the required import license.

	3.6
	Distributor Personnel.    

	3.6.1
	Full-Time, Dedicated Personnel:    Distributor will provide full-time, dedicated personnel that
will include a general manager, a senior product manager and support staff, five to 

4

 

six
senior sales people with sufficient skill, training and experience to be effectively capable of selling a $4 million product, and two clinical support or training specialists. These
personnel will be full-time, one hundred percent (100%) dedicated to the business relating to Accuray's Products and Services and will have adequate backgrounds in surgical and/or
radiation oncology products and services, experience and training to perform the following functions: 

	3.6.1.1
	Sales,
sales management, sales forecasting, and order management;

	3.6.1.2
	Marketing
throughout the Territory;

	3.6.1.3
	Planning
for the installation and installing Products;

	3.6.1.4
	Clinical
trials, regulatory compliance, and reimbursement;

	3.6.1.5
	Product
management;

	3.6.1.6
	Development
of on-site training as described in Exhibit C;

	3.6.1.7
	Provision
of Services; and

	3.6.1.8
	Field
service.

	3.6.2
	Other Personnel:    Distributor will also provide adequate technical support staff for the operation and maintenance of the
Products and Services.

	3.7
	Section
deleted.

	3.8
	Installing Existing Meditec Sites.    Meditec currently has [*] ([*])
existing contracts with Customers, as listed in Exhibit E. Accuray understands that Meditec and Distributor are currently negotiating the terms
to transfer or assignment of such Customers' agreements to Distributor (at which point they will become Transitional Customers).

	3.8.1
	Transition Customer Contract Reports:    Distributor will inform Accuray of the terms of any agreements it enters into with
or regarding each Transitional Customer.

	3.8.2
	Installation Assistance:    Once such Customers have been transferred or assigned from Meditec to Distributor, Distributor
will be responsible for installing the Product at the Transitional Customer's sites and will engage ATC and, as necessary, Accuray to perform the installations. Distributor will pay Accuray for
such services.

	3.8.3
	Installation Reimbursement:    Accuray understands that Distributor and Meditec are negotiating the level of reimbursement
from Meditec for the cost of installation services, including importation, radiation protection calculations, first year warranty labor, and a transfer fee, as necessary.

	3.8.4
	Acceptance and Release:    Once such Customers have been transferred or assigned from Meditec to Distributor, Distributor,
with assistance from Meditec, will obtain appropriate acceptance and release documentation from each Transitional Customer following installation, which will list any further commitments that are
outstanding.

	3.8.5
	Upgrades:    Pursuant to Paragraph 3 of the December 10, 2003, Letter Agreement between Accuray and Meditec,
Meditec has agreed to satisfy any further commitments that are based on previous agreements between the Transitional Customer and Meditec, which may include the delivery to Transitional Customers by
Accuray of additional Product capabilities, if and when regulatory approval is received. 

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

5

 

	3.9
	Additional Meditec Inventory.    Meditec has purchased and has in inventory additional Products
("Meditec Inventory") apart from the Transitional Customer systems referred to above. Distributor will purchase Meditec Inventory, unless prohibited by
law from doing so, to satisfy Customer demand. Notwithstanding the preceding sentence, Distributor will fulfill its minimum volume of Orders and Purchase Orders set forth in
Section 3.13 below.

	3.9.1
	If
Meditec has an upgraded (in compliance with the current Shonin) system in its inventory, to satisfy Distributor's sales demand, Distributor will order a system from Meditec.
Distributor's purchase price for such systems will be $[*].

	3.9.2
	Distributor
shall enter into an Agreement with Meditec determining the level of reimbursement from Meditec for the cost of installation services, including importation, radiation
protection calculations, first year warranty labor, and a transfer fee, as necessary, for such Meditec Inventory.

	3.9.3
	Distributor
will provide training to these Customers as provided in Exhibit C.

	3.10
	Proposals.    Distributor will submit a timely Proposal on every Project in the Territory during the Term of this Agreement.
All Proposals shall be prepared and submitted to the Customer by Distributor. Proposals will offer only Products or Services described in current Specifications, and only in accordance with this
Agreement. Unless Distributor has prior written consent from Accuray to the contrary, all Proposals submitted by Distributor are (and Distributor must inform the Customer that they are) subject
to change in the event Accuray's Terms of Sale or Specifications change prior to the time Distributor accepts an Order from the Customer (if it does). The accuracy and cost of any translation
of Accuray materials, which may be required for a particular Customer, shall be the responsibility of Distributor.

	3.11
	Orders.    Distributor will receive each Order placed by a Customer to which Distributor has submitted a Proposal. Orders
may be accepted only by Distributor. The resulting contract for the sale of Products and Services shall be between Distributor and the Customer. In the case of a Product, Distributor must send a
Purchase Order to Accuray at least six months prior to the expected shipment date. With regards to the systems listed in Exhibit B, this
Agreement constitutes a Purchase Order. All Products must be purchased from Accuray unless otherwise specified in this Agreement or agreed in writing by Accuray.

	3.12
	Payment.    Terms of payment for all Products and Services ordered by Distributor from Accuray shall be net thirty
(30) days from the date of shipment or service unless otherwise agreed. Accuray will bear the cost of any commission charge for a wire transfer. Distributor will pay a late charge of two
percent (2%) on any balance that becomes overdue, plus interest at the rate of one percent (1%) per month or the highest interest rate allowed by law, whichever is greater, until paid. Payment for
Products and Services shall be made in US Dollars by Distributor to Accuray by wire transfer or, at Accuray's election, in the form of irrevocable trade finance letter of credit issued by
Distributor's bank, confirmed by a bank which is doing business in the State of California, United States of America, in all respects acceptable to Accuray, and delivered to Accuray with the
Purchase Order. Payment for a CyberKnife will be made according to the following schedule:

	3.12.1
	$[*]
six (6) months prior to the expected date of shipment of an Order/Purchase Order, or date of shipment as specified in  Exhibit B;

	3.12.2
	$[*]
within thirty (30) days following shipment of the CyberKnife to Distributor, and, 

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

6

 

	3.12.3
	The
remaining balance ninety (90) days after shipment of the CyberKnife.

	3.13
	Volume of Business.    Accuray and Distributor have reviewed and discussed the Territory in detail and have agreed that
Distributor will meet the minimum volume of Orders and Purchase Orders set forth in Exhibit B attached to this Agreement. If Distributor does not
make the minimum purchases set forth in Exhibit B, or does not pay timely (within sixty (60) days of the due date) for those purchases,
Accuray may, at its sole determination and in its sole and complete discretion, elect to make this distribution arrangement non-exclusive.

	3.14
	Forecast.    In order to support Accuray's production planning, at least every six months during the Term of this Agreement,
Distributor will provide Accuray an eighteen (18) month rolling forecast of: targeted Customers, contracted Customers and forecast of Product sales by product line.

	3.15
	Software Service Upgrades.    Distributor must purchase annual service upgrade packages from Accuray for each Customer and
each Transitional Customer. Distributor may choose between (i) the Service Upgrade package and (ii) the Gold Service Contract, each of which is described in Exhibit A.

	3.16
	Customer Support.    Distributor will support Accuray's training of new Customer personnel, and will send new Customer users
for training at Accuray, in accordance to and at the prices listed in Exhibit C. Distributor will provide guidance to billing and
reimbursement personnel of each Customer regarding regulatory and billing requirements and reimbursement for treatment provided with Products under applicable radiosurgical reimbursement codes
applicable within the Territory, Distributor will be responsible for ensuring that its personnel maintain their proficiency with respect to the Products and all upgrades, enhancements and new feature
releases, and will send its personnel to Accuray for training as necessary.

	3.17
	Customer Relations.    Distributor shall deliver Products and Services to Customers in the Territory, shall report promptly
to Accuray any complaints or expressions of dissatisfaction by the Customer relating to the Products or Services. While Distributor shall have no authority to offer on behalf of Accuray anything in
settlement of any such complaints or expressions, Distributor shall use all best efforts to satisfy the Customer that the Products and Services meet the applicable Specifications, Proposal, and Order,
if such is the case.

	3.18
	Installation.    Distributor will be responsible for providing installation for any Product a Customer purchases.

	3.19
	Warranty.    Distributor will be responsible for providing a one (1) year warranty (for parts and service) for
each Product a Customer purchases. Distributor will not make any other warranties or representations in Accuray's name or on Accuray's behalf.

	3.19.1
	Extended Parts Warranty.    Distributor may include Accuray Extended Parts Warranty as an option for Customer in all
service packages. Accuray's Extended Parts Warranty is detailed in Exhibit A.

	3.20
	Field Service.    Distributor will provide to all Customers, remotely and on-site when needed, routine
maintenance and service and timely response to special requests for service of all installed Products in the Territory.

	3.21
	Hardware Parts Inventory.    Distributor will provide rent-free space for Accuray to maintain its hardware parts
inventory of spare parts. At Accuray's request, Distributor will manage the inventory for a fee to be determined and Distributor may invoice Accuray for this service. 

7

 

	3.22
	Records and Reports.

	3.22.1
	Reports.    Within thirty (30) days after the end of each quarter, Distributor will provide Accuray with a written
report that includes: (i) Distributor's sales and shipments of each Product for that quarter, by dollar or yen volume and number of units, both in the aggregate and for such categories as
Accuray may designate from time to time; (ii) service reports detailing all uptime and parts warranty issues; and (iii) any other information requested by Accuray, Distributor's report
will comply in form and substance with Accuray's reporting requirements, as they are determined by Accuray and communicated to Distributor from time to time.

	3.22.2
	Notification.    Distributor will promptly notify Accuray of any: (i) claim or proceeding involving the Products;
or (ii) claimed or suspected Product defects.

	3.22.3
	Records.    During the term of this Agreement and for a period of three (3) years after any termination or
expiration thereof, Distributor will maintain complete and accurate books, records and accounts relating to the distribution of the Products, and will permit Accuray's authorized representatives to
examine them on reasonable prior notice.

	3.23
	Compliance with Laws.

	3.23.1
	Within the Territory.    When Products are being shipped to Distributor, unless the particular Order provides otherwise,
Distributor shall be responsible for all import duties and other import, licensing and immigration formalities which must be complied with in order for the Products to be lawfully imported into the
Territory or the Services to be lawfully performed in the Territory. Although Accuray will retain regulatory responsibility for the Shonin, compliance with all other laws and regulations are the
responsibility of Distributor. Distributor will notify Accuray of any impending changes to Japanese laws or regulatory requirements that pertain to, and may necessitate modifications to, the Products
or Services.

	3.23.2
	United States laws.    Distributor understands that, because it is distributing the Products and Services of
Accuray, a company subject to the laws of the United States of America, Distributor must, when carrying out its duties under this Agreement, avoid violations of certain of such laws. These
include, but are not necessarily limited to, the following:

	3.23.2.1
	Restrictive Trade Practices or Boycotts, U.S. Code of Federal Regulations Title 15, Chapter VII, Part 760.

	3.23.2.2
	Foreign Corrupt Practices Act, U.S. Code Title 15, § 78.

	3.23.2.3
	Export Controls, imposed by U.S. Executive Order or implementing regulations of the U.S. Departments of Commerce,
Defense or Treasury.

	3.24
	Translations.    To the extent it deems necessary, Distributor may, at its option and expense, translate or localize any
product specifications and promotional literature Accuray has provided to Distributor, provided that Accuray has reviewed and given Distributor written approval for each such translation prior to its
use or distribution to Customers.

	3.25
	Insurance.    Distributor shall obtain and keep in full force and effect during the Term of this Agreement
(and thereafter until all Projects as to which Accuray has accepted an order from Distributor have been completed) general and products liability and workers' compensation insurance on an
occurrence basis with coverage limits (i) in the normal and customary business of a medical device distributor and (ii) sufficient to provide coverage of any claim which may reasonably
arise out of the actions or inactions of that party related to this Agreement or the business relationship between the parties. Distributor shall provide to 

8

 

Accuray
from time to time while its obligation under this paragraph is in effect certificates evidencing such insurance, which certificates shall expressly provide that the underlying coverage cannot
be cancelled without at least thirty (30) days' written notice to Accuray. 

	3.26
	Competing Products.

	3.26.1
	During
the Term of this Agreement, Distributor will not, with respect to Customers located or having Projects in the Territory, sell, offer for sale, promote the sale of,
distribute or represent in any way products or services which are competitive with the Products or Services.

	3.26.2
	By
April 30, 2004, until the termination of this Agreement, Distributor agrees that it will cease (i) assisting Elekta with any Elekta Products, (ii) selling
Electa products and (iii) servicing Elekta products. Elekta products include, but are not limited to, the Gamma Knife. 

4.     Compensation and Payment  

	4.1
	Compensation.    Except as otherwise provided herein, Distributor's only compensation for its efforts on Accuray's behalf
shall be the margins it earns on the resale of Products and Services, and Distributor shall bear all of the expenses which it incurs in making those efforts.

	4.2
	Payment.    Distributor shall be solely responsible for determining the creditworthiness of and collecting payment from its
Customers. The risk of non-collection from the Customer will be borne entirely by Distributor, which shall be responsible for making timely payment to Accuray for Products and Services
whether or not Distributor is successful in collecting from its Customer. 

5.     Term and Termination  

	5.1
	Term.    The Term of this Agreement shall begin on the Effective Date and continue until December 31, 2006, unless
extended or sooner terminated in accordance with this Section 5.

	5.2
	Renewal.    This Agreement will be renewed for additional one-year periods, at the option of Distributor, if
Distributor has carried out its duties under this Agreement, including meeting the minimum volume of purchases and shipments set forth in  Exhibit B, as updated in accordance with the following.
Accuray and Distributor will meet approximately one hundred eighty (180) days
prior to the termination date and agree upon a Volume of Business, a number of Customer orders, and any other terms, for the subsequent renewal period. It is anticipated that the Volume of Business
and number of Customer orders for 2006 shall be for no more than [*] ([*]) CyberKnife systems and no less than [*]
([*]) systems. Thereafter, the Volume of Business and number of Customer orders for each subsequent renewal year shall reflect an increase in units over the numbers determined
for the previous year. Either party may terminate this Agreement at the end, or following the end, of the second renewal year with one hundred eighty (180) days prior written notice to the
other party.

	5.3
	Termination for Cause.    Either party may terminate this Agreement if the other party commits a material breach of this
Agreement and fails to cure it within thirty days after written notice of the breach is given by the other party, provided that, as to a breach which cannot be fully cured within thirty days, that
breach shall be deemed timely cured if the cure is commenced immediately upon receipt of notice of it from the other party and pursued diligently to completion. The effective date of termination shall
be the date of expiration of the cure period without a cure having occurred. 

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

9

 

	5.4
	Termination Without Cause.    Either party may terminate this agreement with twelve (12) months prior written notice
to the other party. Each party shall diligently pursue its obligations under this Agreement until the date of termination.

	5.5
	Accruals.    No termination of this Agreement will terminate any obligation of payment which has accrued prior to the
effective date of such termination.

	5.6
	Termination Transition Assistance.    Immediately following termination, Distributor shall transfer to Accuray: Accuray's
parts inventory; any license or permit obtained for conduct of the business in Japan; any Confidential Information and other items as will be negotiated in good faith between the parties. Furthermore,
the parties agree to cooperate fully with the other for any reasonable transition assistance required in the case of termination or expiration of this Agreement.

	5.7
	No Termination Compensation.    Distributor waives any rights it may have to receive any compensation or indemnity upon
termination or expiration of this Agreement, other than as expressly provided in this Agreement. Distributor acknowledges that it has no expectation and has received no assurances that any investment
by Distributor in the promotion of the Products will be recovered or recouped or that Distributor will obtain any anticipated amount of profits by virtue of this Agreement. 

6.     Dispute Resolution  

	6.1
	Applicable law.    This Agreement shall be subject to and controlled by the laws of the State of California, not including
either the choice of law/conflict of laws rules of California or international treaties (such as the U.N. Convention on Contracts for the International Sale of Goods) which would otherwise be
applicable in California.

	6.2
	Notification and Discussion.    Accuray and Distributor hereby irrevocably and unconditionally agree as follows: Should any
dispute arise between the parties relating to this Agreement or the business relationship between the parties, such dispute shall be submitted by one or both parties, in writing, to the Chief
Executive Officer of Distributor and Accuray's President (the "Principal Officers") for resolution. The parties shall attempt to resolve any dispute arising out of relating to this Agreement
promptly by negotiation between executives who have authority to settle the controversy.

	6.3
	Process.    Any controversy, claim or dispute arising out of or relating to this Agreement, including without limitation, the
construction, interpretation, validity, enforcement, performance, lack or failure of performance or breach of this Agreement, or the rights, duties or liabilities of a party under this Agreement, that
cannot be resolved by agreement of the parties within fifteen (15) days of the matter being raised, and either party wishes to pursue the matter, the controversy, claim or dispute shall be
referred to further dispute resolution processes in accordance with Exhibit F.

	6.4
	Confidential Information.    Any breach of Accuray Intellectual property or confidential information as described in  Section 7 below or related obligations of this Agreement will cause Accuray irreparable harm for which money damages shall be an inadequate
remedy and difficult to ascertain. Consequently, notwithstanding anything else in this Agreement to the contrary, in the event of any such threatened or actual breach, Accuray will be entitled to seek
equitable relief in any court having jurisdiction on any claim based upon the actual or imminent misuse or unauthorized disclosure of Accuray intellectual property or confidential information,
including preliminary injunctions restraining such breach and specific performance of Distributor's obligations and covenants in such sections. Such equitable relief shall be in addition, and without
prejudice, to any other remedies available to Accuray at law 

10

 

or
under this Agreement for any such breach or threatened breach. If Accuray seeks injunctive relief, such action shall not constitute a waiver of the provisions of this Agreement to arbitrate, which
shall continue to govern any and every dispute between the parties including, without limitation, the right of damages, permanent injunctive relief, and any other remedy at law or in equity. 

7.     Confidentiality.  

	7.1
	Definition.    "Confidential Information" means: (i) any non-public,information of a party, including,
without limitation, any information relating to a party's current and planned products and services, technology, techniques, know-how, research, engineering, designs, finances, accounts,
procurement requirements, manufacturing, customer lists, business forecasts and marketing plans; (ii) any other information of a party that is disclosed in writing and is conspicuously
designated as 'Confidential" at the time of disclosure or that is disclosed orally, is identified as "Confidential" at the time of disclosure, and is summarized in a writing sent by the disclosing
party to the receiving party within thirty (30) days of any such disclosure; and (iii) the specific terms and pricing set forth in this Agreement.

	7.2
	Exclusions.    The obligations in Section 7.3 will not apply to the
extent any information: (i) is or becomes generally known to the public through no fault of or breach of this Agreement by the receiving party; (ii) was rightfully in the receiving
party's possession at the time of disclosure, without an obligation of confidentiality; (iii) is independently developed by the receiving party without use of the disclosing party's
Confidential Information; or (iv) is rightfully obtained by the receiving party from a third party without restriction on use or disclosure.

	7.3
	Obligations.    Each party will not use the other party's Confidential Information, except as necessary for the performance
of this Agreement, and will not disclose such Confidential Information to any third party, except to those of its employees and subcontractors that need to know such Confidential Information for the
performance of this Agreement, provided that each such employee and subcontractor is subject to a written agreement that includes binding use and disclosure restrictions that are at least as
protective as those set forth herein. Each party will use all commercially reasonable efforts to maintain the confidentiality of all of the other party's Confidential Information in its possession or
control, but in no event less than the efforts that it ordinarily uses with respect to its own confidential information of similar nature and Importance. The foregoing obligations will not restrict
either party from disclosing the other party's Confidential Information or the terms and conditions of this Agreement: (i) pursuant to the order or requirement of a court, administrative
agency, or other governmental body, provided that the party required to make such a disclosure gives reasonable notice to the other party to enable it to contest such order or requirement;
(ii) on a confidential basis to its legal or professional financial advisors; (iii) as required under applicable securities regulations; or (iv) on a confidential basis to present
or future providers of venture capital and/or potential private investors in or acquirers of such party. 

8.     Indemnities.  

	8.1
	Accuray Indemnity.    Accuray will defend or settle any action brought against Distributor to the extent that it is based
upon a third-party claim that a Product, as provided by Accuray to Distributor under this Agreement, infringes any United States patent or any copyright or misappropriates any trade secret, and
will pay any costs and damages made in settlement or awarded against Distributor in final judgment resulting from any such claim, provided that Distributor: (i) gives Accuray prompt notice of
any such claim; (ii) gives Accuray sole control of the defense and any related settlement of any such claim; and (iii) gives Accuray, at 

11

 

Accuray's
expense, all reasonable information, assistance and authority in connection with the foregoing. Accuray will not be bound by any settlement or compromise that Distributor enters into without
Accuray's express prior consent. 

	8.2
	Injunctions.    If Distributor's rights to use and distribute a Product under the terms of this Agreement is, or in Accuray's
opinion is likely to be, enjoined due to the type of claim specified in Section 8.1, then Accuray may, at its sole option and expense:
(i) procure for Distributor the right to continue to use and distribute such Product under the terms of this Agreement; (ii) replace or modify such Product so that it is
non-infringing; or (iii) if options (i) and (ii) above cannot be accomplished despite Accuray's reasonable efforts, then Accuray may terminate Distributor's rights and
Accuray's obligations hereunder with respect to such Product and credit to Distributor the amounts paid for such Product during the twelve (12) months prior to the date Accuray issues such a
credit, provided that all units of such Product are returned to Accuray in an undamaged condition.

	8.3
	Indemnity Exclusions.    Accuray will have no obligation under  Sections 8.1
or 8.2 for any claim of infringement or misappropriation to the extent that
it results from: (i) the combination, operation or use of a Product with or in equipment, products, or processes not provided by Accuray; (ii) modifications to a Product not made by or
for Accuray; (iii) Distributor's failure to use updated or modified Products provided by Accuray; (iv) Distributor's use or distribution of a Product other than in accordance with this
Agreement or (v) Distributors contracts with other manufacturers, including Elekta and manufacturers of products and services that compete with Accuray. The foregoing clauses (i)
to (v) are referred to collectively as "Indemnity Exclusions".

	8.4
	Limitation.    THE FOREGOING PROVISIONS OF THIS SECTION 8 SET FORTH
ACCURAY'S SOLE AND EXCLUSIVE LIABILITY AND DISTRIBUTOR'S SOLE AND EXCLUSIVE REMEDY FOR ANY CLAIMS OF INFRINGEMENT OR MISAPPROPRIATION OF INTELLECTUAL PROPERTY RIGHTS OR PROPRIETARY RIGHTS OF
ANY KIND.

	8.5
	Distributor Indemnity.    Distributor will defend or settle, indemnify and hold Accuray harmless from any liability, damages
and expenses (including court costs and reasonable attorneys' fees) arising out of or resulting from any third-party claim based on or otherwise attributable to: (i) Distributor acts or
omissions; (ii) any misrepresentations made by Distributor with respect to Accuray or the Products or Services; or (iii) an Indemnity Exclusion. 

9.     Liability.  

	9.1
	Exclusion of Certain Damages.    IN NO EVENT WILL ACCURAY BE LIABLE FOR ANY SPECIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL
DAMAGES (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS OR REVENUE, LOSS OF USE, LOST BUSINESS OPPORTUNITIES OR LOSS OF GOODWILL), OR FOR THE COSTS OF PROCURING SUBSTITUTE PRODUCTS, ARISING OUT OF,
RELATING TO OR IN CONNECTION WITH THIS AGREEMENT OR THE USE OR PERFORMANCE OF ANY ACCURAY PRODUCTS OR SERVICES PROVIDED BY ACCURAY, WHETHER SUCH LIABILITY ARISES FROM ANY CLAIM BASED UPON CONTRACT,
WARRANTY, TORT (INCLUDING NEGLIGENCE), PRODUCT LIABILITY OR OTHERWISE, WHETHER OR NOT ACCURAY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSS OR DAMAGE. THE PARTIES HAVE AGREED THAT THESE LIMITATIONS
WILL SURVIVE AND APPLY EVEN IF ANY LIMITED 

12

 

REMEDY
SPECIFIED IN THIS AGREEMENT IS FOUND TO HAVE FAILED OF ITS ESSENTIAL PURPOSE. 

	9.2
	Total Liability.    ACCURAY'S TOTAL LIABILITY TO DISTRIBUTOR UNDER THIS AGREEMENT, FROM ALL CAUSES OF ACTION AND UNDER ALL
THEORIES OF LIABILITY, WILL BE LIMITED TO THE PAYMENTS ACTUALLY RECEIVED FROM DISTRIBUTOR UNDER THIS AGREEMENT DURING THE TWELVE (12) MONTH PERIOD PRECEDING THE DATE A CLAIM FOR LIABILITY
ARISES HEREUNDER

	9.3
	Basis of Bargain.    The parties expressly acknowledge and agree that Accuray has set its prices and entered into this
Agreement in reliance upon the limitations of liability specified herein, which allocate the risk between Accuray and Distributor and form an essential basis of the bargain between the parties. 

10.   Miscellaneous Provisions  

	10.1
	Publicity.    Distributor may not use Accuray's name or trademarks on its literature, signs, or letterhead, nor may it make
press releases or other public statements disclosing its relationship with Accuray under this Agreement or otherwise without the prior written consent of Accuray.

	10.2
	Titles.    Titles of the various paragraphs and sections of this Agreement are for ease of reference only and are not
intended to change or limit the language contained in those paragraphs and sections.

	10.3
	Writing.    It is the intention of the parties that this written Agreement contains the entire agreement between them. No
addition to or amendment of this Agreement shall have any effect unless it is also in writing and, with the exception of those matters which Accuray is expressly permitted to change from time to time
during the Term of this Agreement (such as Pricing, Terms of Sale, etc.), shall only be valid if signed by the duly authorized officers of both parties. 

13

 

Signatures:  

	DISTRIBUTOR:	 	ACCURAY INCOROPRATED:
	 	 	 	 	 
	 	 	 	 	 
	By:	/s/ Toshikazu Hosoda
	 	By:	/s/ Euan S. Thomson

	 	 	 	 	 
	 	 	 	 	 
	Typed Name:	Toshikazu Hosoda
	 	Typed Name:	Euan S. Thomson

	 	 	 	 	 
	 	 	 	 	 
	Title:	President and CEO
	 	Title:	President and CEO

	 	 	 	 	 
	 	 	 	 	 
	Date:	21 Jan. 2004
	 	Date:	21 Jan. 2004

 
 

[SIGNATURE PAGE TO THE ACCURAY INCORPORATED
  INTERNATIONAL DISTRIBUTOR AGREEMENT]    

14

   Exhibit A  

PRODUCTS AND SERVICES (INCLUDING CURRENT PRICING)  

This Exhibit may be updated from time to time  

	(*)
	The
price of the service upgrade package is subject to further negotiation and will be determined by mutual agreement within thirty (30) days of the signature date of
this Agreement.

	(**)
	The
price of the High Throughput upgrade package, including Modified Linac output (400 MU/min), is subject to further negotiation, but will not be less than
$[*], and will be determined by mutual agreement within thirty (30) days of the signature date of this Agreement. 

	Qty
 
	 	Product Description

	 	Chiyoda

Transfer Price

	

	

 	
 	
CyberKnife II	
 	
$[*]
	 	 	Robot	 	Incl.
	

	
 1	
 	

Robot Manipulator	
 	

Incl.
	1	 	Robot Control Unit	 	Incl.
	
 	
 	
Linac	
 	

 
	1	 	Compact 6MV Linac (300 cGy/min)	 	Incl.
	 	 	Secondary Collimator Kit — 5mm, 7.5 mm, 10 mm, 12.5	 	 
	1	 	15 mm, 20 mm, 25 mm, 30 mm, 35 mm, 40 mm, 50 mm, 60 mm, Blank	 	Incl.
	1	 	Chiller Rack Mount	 	Incl.
	1	 	EPO Op Console	 	Incl.
	
 	
 	
Couch	
 	

 
	1	 	5 Axis Motorized Treatment Couch (Low)	 	Incl.
	1	 	Couch Hand Controller	 	Incl.
	1	 	Tabletop Mattress	 	Incl.
	
 	
 	
Imaging System	
 	

 
	2	 	Imaging Stands (Low)	 	Incl.
	2	 	Amorphous Silicon Detectors	 	Incl.
	2	 	X-ray Generators	 	Incl.
	2	 	X-Ray Sources	 	Incl.
	1	 	TLS PC	 	Incl.
	1	 	TDS Software	 	Incl.
	
 	
 	
Sub-system Controls	
 	

 

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

16

 

	1	 	Power Distribution Unit	 	Incl.
	1	 	Interface Control Chassis	 	Incl.
	1	 	Control Modulator MCC	 	Incl.
	1	 	ESCC Control Chassis	 	Incl.
	1	 	TLSCC	 	Incl.
	1	 	Equipment Rack	 	Incl.
	1	 	PC Monitor	 	Incl.
	1	 	Keyboard & Mouse	 	Incl.
	1	 	3-way KVM Switch	 	Incl.
	
 	
 	
CyberKnife Software System	
 	

 
	1	 	Treatment Delivery Software License	 	Incl.
	1	 	Cranial treatment Skull Tracking	 	Incl.
	1	 	Treatment Planning Software License	 	Incl.
	
 	
 	
Hardware Components	
 	

Incl.
	

	
 1	
 	

Serial Port Server	
 	

Incl.
	1	 	SGI Octane II Workstation (Primary)	 	Incl.
	 	 	Dual R12000A 400MHz/2MB cache	 	 
	 	 	512 MB Memory	 	 
	 	 	18 GB 10,000 RPM System Disk	 	 
	 	 	21" Color Monitor VGA — Flat Trinitron Tilt/Swivel	 	 
	
 	
 	
DAT20-INT Internal 4mm SCSI Tape, 20GB — Patient Data Archive/Restore	
 	

 
	 	 	40x SCSI CD-ROM Drive	 	 
	 	 	IRIX Operating System	 	 
	 	 	Mouse and Keyboard	 	 
	 	 	Power Cords	 	 
	
 1	
 	

SMART UPS	
 	

Incl.
	1	 	SGI Octane II Workstation (Primary)	 	Incl.
	 	 	Dual R12000A 400MHz/2MB cache	 	 
	 	 	512 MB Memory	 	 
	 	 	18 GB 10,000 RPM System Disk	 	 
	 	 	21" Color Monitor VGA — Flat Trinitron Tilt/Swivel	 	 
	
 	
 	
DAT20-INT Internal 4mm SCSI Tape, 20GB — Patient Data Archive/Restore	
 	

 
	 	 	40x SCSI CD-ROM Drive	 	 
	 	 	IRIX Operating System	 	 
	 	 	Mouse and Keyboard	 	 
	 	 	Power Cords	 	 
	
 	
 	
Manuals and IFU's	
 	

Incl.
	1	 	CyberKnife II System Manuals & CD's	 	Incl.
	1	 	Kuka Manipulator System Manuals	 	Incl.
	1	 	Chiller Manual	 	Incl.
	1	 	X-ray Detector Manuals	 	Incl.
	1	 	Accuray 6MEV Medical X-ray CD	 	Incl.
	1	 	X-Ray Generator Manual	 	Incl.
	1	 	Couch	 	Incl.

17

 

	 	 	QA Tools	 	Incl.
	1	 	Anthro 6D Head Phanton	 	Incl.
	1	 	Ball Cube	 	Incl.
	1	 	Pre-notched Dosimetry Film (20 Pieces)	 	Incl.
	1	 	QA Calibration Tool	 	Incl.
	1	 	Pinhole Collimator Align Tool	 	Incl.
	1	 	Digital Level (1/10 degree)	 	Incl.
	1	 	Ion Chamber Test Fixture	 	Incl.
	1	 	Assy ISO Post	 	Incl.
	1	 	Alignment Ball	 	Incl.
	1	 	Pointer Calibration & Front Pointer	 	Incl.
	
 	
 	
Team Training	
 	

 
	1	 	Technical & Clinical 5 persons (offered by CT)	 	 
	1	 	Onsite Training (offered by CT)	 	 
	1	 	Basic Physics and QA (offered by CT)	 	 
	
 	
 	
Installation Kit	
 	

Incl.
	1	 	8' Ladder	 	Incl.
	1	 	Wrench allen Set	 	Incl.
	
 	
 	
Miscellaneous Components	
 	

Incl.
	1	 	Color Laser Printer	 	Incl.

	
CK II Options
	
 	
 	
Service Upgrade Package	
 	

 	
 	

 
	 	 	(annual)	 	(*)	 	not incl.
	1	 	Software diagnostic improvements, improved mathematical modeling, improved algorithms, bug-fixes, error corrections and Other service enhancements. No new features	 	 	 	 
	
 	
 	
Gold Service Contract Package	
 	

 	
 	

 
	 	 	(software purchase contract; annual)	 	$[*]	 	Not incl.
	1	 	One new software package / year	 	 	 	 
	 	 	(i)  Transitional Customers are entitled to all software

      Upgrades that are available for installation in the Territory During the Term.	 	 	 	 
	 	 	(ii)  For Transitional Customers, the Gold Service Contract is effective for (4) years commencing on the Installation completion date.	 	 	 	 
	 	 	(iii)  Payments are due annually, in advance.	 	 	 	 
	
 	
 	
High Throughput (hardware + software)	
 	

(**)	
 	

 
	1	 	Modified Linac output (400 MU/min)	 	 	 	not incl.
	1	 	Express Software Module	 	 	 	Incl./w/Gold

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

18

 

	 	 	Service Items	 	 	 	not incl.
	1	 	Extended Parts Warranty per year	 	¥ [*]	 	not incl.
	 	 	(Provides all parts for field service and maintenance, payable quarterly in advance. This pricing is based on twenty (20) Customers committing to this program. If less than twenty (20) Customers commit, Accuray
reserves the right to increase the price or cancel the program.)	 	 	 	 
	
 	
 	
Additional Treatment Planning Station	
 	

$[*]	
 	

not incl.
	 	 	1 Treatment Planning Software License	 	 
	 	 	Dual R12000A 400MHz/2MB cache	 	 
	 	 	512 MB Memory	 	 
	 	 	18 GB 10,000 RPM System Disk	 	 
	 	 	21" Color Monitor VGA — Flat Trinitron Tilt/Swivel	 	 
	
 	
 	

DAT20-INT Internal 4mm SCSI Tape, 20GB — Patient Data Archive/Restore	
 	

 
	 	 	40x SCSI CD-ROM Drive	 	 
	 	 	IRIX Operating System	 	 
	 	 	Power Cords	 	 
	
 	
 	
Additional Computer Items	
 	

not incl.
	1	 	Additional 73 Gbyte Hard Disk (upgrade)	 	$[*]	 	not incl.
	1	 	21" flat panel LCD monitor (upgrade	 	$[*]	 	not incl.
	1	 	Cable Kit Add Octane to Hub	 	$[*]	 	not incl.
	1	 	SGI 36 Gig Hard drive	 	$[*]	 	not incl.
	1	 	SGI 18 Gig Hard drive	 	$[*]	 	not incl.
	1	 	SGI Memory, 512MB	 	$[*]	 	not incl.
	
 	
 	
Additional Hardware Items	
 	

not incl.
	1	 	Headrest w/Medtec mask (GE)	 	$[*]	 	not incl.
	1	 	CT adapter — GE Lightspeed (no HDR)	 	$[*]	 	not incl.
	1	 	CT adapter w/HDR — Siemens	 	$[*]	 	not incl.
	1	 	Headrest w/ Medtec mask	 	$[*]	 	not incl.
	1	 	Additional QA Items	 	not incl.
	1	 	Alignment Jig 6D — 20cm	 	$[*]	 	not incl.
	1	 	Head Phantom Kit (contains ball cube)	 	$[*]	 	not incl.
	1	 	Gas Chromic Film (20 pack)	 	$[*]	 	not incl.
	1	 	Film Ball cube (20 pack)	 	$[*]	 	not incl.

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

19

  

 
 

Exhibit B
  
    PRODUCT AND SERVICE MINIMUM VOLUMES    
    

In
addition to Meditec Orders, Distributor agrees to purchase, at a minimum, during the initial term of the contract ending December 31, 2006, and Accuray shall ship [*]
CyberKnife systems on the dates specified: 

[*]
(***)

[*] (***)

[*]

[*]

[*] 

(***)    The
dates of shipment of the first [*] systems are subject to final negotiation and will be determined by mutual agreement within thirty (30) days of
the signature date of this Agreement. 

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

20

  

 
 

Exhibit C
  
    TRAINING    
    

	Phase
 
	 	Details
 
	 	Accuray Training

Obligations
 
	 	Distributor Training

Obligations
 

	Phase 1:

 Upgrade Training

(current Meditec customers to be reinstalled and upgrade training to be conducted)	 	Number: 1 - 10 sites

 Training consisting of:

(i) Technical

(ii) Onsite

 Timing:

(i) Users will review new hardware and new software changes prior to installation or prior to first patient treatments

(ii) Technical support to be provided by Accuray during the initial patient treatments.

 Funding: Customer training to be funded by Accuray.	 	Technical Training:

• Train 2-3 people/site

• Train 2-3 sites together up to

    6 people/training

• 1.5 days at Accuray's Corporate

    Training Center

    • Faster, more accurate skull

       tracking algorithm

       • Submillimeter

           accuracy tracking

    • Importing DICOM RT files

    • Medical Imaging Import Tool (MIRIT)

    • Accufusion

    • Software and hardware

       changes associated with

       Express

    • Enhanced QA program

       • Ball cube

       • Automated QA

           treatment planning

       • BB test

    • KUKA robot

       • Use of the teach pendant

       • Manipulation of the robot

       • Troubleshooting the robot

    • Changes to recoverable

       and unrecoverable error

       handing

    • Changes to Treatment

       Planning System (TPS)

    • Changes to proximity

       detection program (PDP)

• Day at Stanford University

    Hospital observing patient

       treatments

    • Clinical observation of

       patient treatments

    • Discussions with peers

 Clinical Training:

• None.

 Onsite Training:

• 1-2 days conducted at the

    customer site

• Provide technical support

    for new software and

    hardware changes with

    initial patients

• Accuray Training personnel

    to support Chiyoda

    Training Specialist to

    attend, observe and learn	 	Technical Training

• Chiyoda to send 1-2

    people to provide support

    to new customers

 Clinical Training:

• None.

Onsite Training:

• Chiyoda Training Specialist

    to attend, observe and learn.

21

 

	Phase
 
	 	Details
 
	 	Accuray Training

Obligations
 
	 	Distributor Training

Obligations
 

	Phase 2:

Transitional Customers

(Meditec customers not yet installed)	 	Number: Circa 11-16 sites

 Customer Training consisting of:

(i) Technical

(ii) Clinical

(iii) Onsite

 Timing: Training to be conducted prior to installation of the CyberKnife.

 Funding: The Technical, Clinical and Onsite Training funded by Accuray.	 	Technical Training

• Train 2-3 people/sites

• Train 1 team at a time

• 3 days at Accuray's

    Corporate Training Center    

    • Patient setup and

       immobilization

    • CT protocol guidelines

    • Importing DICOM

       RT files and Medical

       Imaging Import Tool

       (MIRIT)

    • Accufusion

    • Basic and Advanced

       use of the Treatment

       Planning System (TPS)

    • Mock patient treatments

       • Faster, more accurate

           skull tracking algorithm

    • Troubleshooting the

       system

       • Handling

           recoverable and

           unrecoverable errors

    • Proximity Detection

       Program (PDP)

    • Manipulation of the

       robot

       • Use of the teach

           pendant

    • QA program

       • Automated QA

           treatment

           planning

       • BB test

       • Film Analysis

    • Beam Commissioning

• 1 days at Stanford

    University Hospital

    observing patient

    treatments

    • Clinical observation

       of patient treatments

    • Discussions with

       peers

 Clinical Training:

• 1 day visit at a Japanese

    Training Center

    • Clinical observation

       of patient treatments

    • Discussions with peers	 	Technical Training

• Chiyoda to send 1-2 people

    to technical training to

    provide support to new

    customers

• Chiyoda Training Specialist

    to observe and learn about

    CyberKnife

22

 

	Phase
 
	 	Details
 
	 	Accuray Training

Obligations
 
	 	Distributor Training

Obligations
 

	 	 	 	 	• Accuray Training personnel

    and Chiyoda Training

    Specialist to support

 Onsite Training:

• 3-5 days conducted at the

    Customer site

• Provide technical support

    during initial patient

    treatments

• Accuray Training personnel

    to support Chiyoda

    Training Specialist to

    attend, observe and learn	 	 
	

	Phase 3:

 New Customers

(new Chiyoda customers)	 	Number: 17-50 sites

 Customer Training

consisting of:

(i) Technical

(ii) Clinical

(iii) Onsite

 Timing: Training to be conducted prior to installation of the CyberKnife following the 3 Sections of Customer Training

 Funding: Clinical and On-site training funded by Chiyoda Technology

 Proposed Training Site Options:

(i) Option 1: Train customers in the US at Accuray Corporate

Training Center for a $[*] for

technical training only; $[*] for

technical training plus 1 day

clinical observation at Stanford

with Stanford CyberKnife Team

    • Chiyoda Technology

       and Accuray Training

       Specialists to conduct

       technical training
 (ii) Option 2: Accuray along

with Chiyoda Technology to

establish and operate Training

Center in Japan modeled after

the Accuray Training Center.

Technical training to be funded

by Chiyoda Technology	 	Technical Training:

• Train 2-3 people/site

• 3 days at Accuray's

    Corporate Training Center

    • Patient setup and

       immobilization

    • CT protocol

       guidelines

    • Importing DICOM

       RT files and Medical

       Imaging Import Tool

       (MIRIT)

    • Accufusion

    • Basic and Advanced

       use of the Treatment

       Planning System

       (TPS)

    • Mock patient

       treatments

    • Troubleshooting the system

       • Handling

           recoverable and

           unrecoverable

           errors

    • Proximity Detection

       Program (PDP)

    • Manipulation of the

       robot

       • Use of the teach

           pendant

    • QA program

       • Automated QA

           treatment

           planning

       • BB test

       • Film Analysis

    • Beam Commissioning	 	Technical Training:

• Chiyoda to send 1-2 people

    to participate in the

    technical training

 Clinical Training:

• Chiyoda Training Specialist

    to support independently

    • Accuray Japanese

       Training Specialist to

       oversee

 Onsite Training:

• Chiyoda Training Specialist

    to support independently

    Accuray Japanese Training

    Specialist to oversee

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

23

 

	Phase
 
	 	Details
 
	 	Accuray Training

Obligations
 
	 	Distributor Training

Obligations
 

	 	 	 	 	Clinical Training:

• 1 day visit at a Japanese

    Training Center

    • Clinical observation

       of patient treatments

    • Discussions with

       peers

• Chiyoda Training Specialist

    to support independently

    • Accuray Japanese

       Training Specialist to

       oversee

 Onsite Training:

• 3-5 days conducted at the

    customer site

• Provide technical support

    during initial patient

    treatments

• Chiyoda Training Specialist

    to support independently

    • Accuray Japanese

       Training Specialist to

       oversee	 	 

24

  

 
 

Exhibit D
  
    Exhibit Deleted    

25

  

 
 

Exhibit E
  
    EXISTING MEDITEC CUSTOMERS    
    

	Site Name
 
	 	Location
 

	Current	 	 
	 	1 Konan St. Hill H.	 	Ube, Yamaguchi
	 	2 Osaka Univ. H.	 	Suita, Osaka
	 	3 Okayama Kyokuto H.	 	Okayama, Okayama
	 	4 Kumamoto Radiosurgery Clinic	 	Kumamoto, Kumamoto
	 	5 Fujimoto Hayasuzu H.	 	Miyakonojo, Miyazaki
	 	6 Kyushu Univ. H.	 	Fukuoka, Fukuoka
	 	7 Imabari Saiseikai H.	 	Imabari, Ehime
	 	8 Kyoto Soseikai H.	 	Kyoto, Kyoto
	 	9 Tobata H	 	Kitakyushu, Fukuoka
	

	
Future	
 	

 
	 	10 [*]	 	[*]
	 	11 Tsushima City H.	 	Tsushima, Aichi
	 	12 [*]	 	[*]
	 	13 Oka H.	 	Oita, Oita
	 	14 Shinryokukai H.	 	Yokohama, Kanagawa
	 	15 Kanto Neurosurgical Hospital	 	Kumagaya, Saitama
	 	     Asanokawa	 	(tent. Install date 3/03)

cancelled

List
based on 9/2/03 Mdt/ATC installation schedule 

These
hospital names may change by mutual agreement within thirty (30) days of the signature date of this Agreement. 

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

26

  

 
 

Exhibit F
  
    DISPUTE RESOLUTION    
    

	1.
	Negotiation.    The parties shall attempt to resolve any dispute arising out of relating to this Agreement promptly by
negotiation between executives who have authority to settle the controversy, as set forth in Section 6 of the Agreement.

	2.
	Mediation.    If the parties do not resolve the dispute within forty-five (45) days of undertaking
negotiation thereof, either Party may refer the Dispute for mediation by the applicable mediation body (as provided below) or its successor (the "Mediation
Organization") by providing the Mediation Organization and the other Party a written request for mediation, setting forth the
details of the dispute and the relief requested. Each Party must then participate in the mediation in good faith and share equally in its costs. If a request for mediation is made, then the mediation
shall take place in Santa Clara County, California. Mediation shall be conducted by JAMS or its successor, in accordance with the JAMS mediation rules and procedures then in effect Any mediation
taking place between the parties will be conducted by: (i) a mediator agreed to by the parties selected from the applicable Mediation Organization's panel of neutrals; or (ii) if the
parties do not agree on a mediator, a mediator nominated by the applicable Mediation Organization. Any mediation taking place between the parties shall be conducted in the English language. All
offers, promises, conduct and statements, whether oral or written, made in the course of the mediation by any of the parties, their agents, employees, experts and attorneys, and by the mediator and
any Mediation Organization employees, are confidential, privileged and inadmissible for any purpose, in any litigation or other proceeding involving the parties, provided that evidence that is
otherwise admissible or discoverable shall not be rendered inadmissible or non-discoverable as a result of its use in the mediation.

	3.
	Arbitration.    If the dispute has not been resolved by non-binding means as provided herein within ninety
(90) days of the initiation of such procedure, either party may initiate arbitration with respect to such matters at any time following the period provided for mediation, or determination by
the mediator that the parties will not be able to resolve the issue through mediation, by filing a written request for arbitration to JAMS, as provided below, in accordance with JAMS arbitration
procedures. If a request for arbitration is made, then the arbitration shall take place in Santa Clara County, California. Any arbitration taking place shall be conducted by JAMS or its successor, in
accordance with the JAMS arbitration rules and procedures then in effect. Any arbitration taking place between the parties shall be conducted in the English language.

	4.
	Other Remedies.    Notwithstanding the foregoing, each Party shall have right before or during negotiation, mediation or
arbitration to seek and obtain from the appropriate court provisional remedies such as attachment, preliminary injunction, replevin, etc., to avoid irreparable harm, maintain the status quo or
preserve the subject matter of the negotiations, mediation or arbitration. 

30

QuickLinks

ACCURAY INCORPORATED INTERNATIONAL DISTRIBUTOR AGREEMENT

[SIGNATURE PAGE TO THE ACCURAY INCORPORATED INTERNATIONAL DISTRIBUTOR AGREEMENT]

Exhibit B PRODUCT AND SERVICE MINIMUM VOLUMES

Exhibit C TRAINING

Exhibit D Exhibit Deleted

Exhibit E EXISTING MEDITEC CUSTOMERS

Exhibit F DISPUTE RESOLUTION

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]